MODE OF ACTION OF ANISODAMINE, AN ANTI-PLATELET AGENT

被引：0
|
作者：
JIANG, YF [1 ]
机构：
[1] SECOND MIL MED UNIV, DEPT BIOCHEM, SHANGHAI, PEOPLES R CHINA
来源：
THROMBOSIS AND HAEMOSTASIS | 1989年 / 62卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：556 / 556
页数：1
相关论文
共 50 条
  • [1] ASPIRIN AS AN ANTI-PLATELET AGENT
    SHAH, R
    ARCHIVES OF INTERNAL MEDICINE, 1980, 140 (12) : 1676 - 1676
  • [2] ANTI-PLATELET ACTION OF TIARAMIDE
    MOTOYAMA, Y
    SAKATA, Y
    YONEDA, Y
    HORIAI, H
    ONO, T
    KIKUCHI, H
    FOLIA PHARMACOLOGICA JAPONICA, 1985, 85 (05) : P43 - P43
  • [3] A NEW ANTI-PLATELET AGENT - TICLOPIDINE
    AUKLAND, A
    STUART, J
    HURLOW, RA
    GEORGE, AJ
    DAVIES, AJ
    BRITISH JOURNAL OF SURGERY, 1981, 68 (11) : 807 - 807
  • [4] Anagrelide is an anti-megakaryocytic and not an anti-platelet agent
    Watson, Steve P.
    Dalby, Amanda
    PLATELETS, 2019, 30 (01) : 136 - 137
  • [5] INVIVO EFFECT OF SULOCTIDIL AS AN ANTI-PLATELET AGENT
    STELZER, MR
    BURNS, TS
    SAUNDERS, RN
    THROMBOSIS AND HAEMOSTASIS, 1979, 41 (03) : 465 - 474
  • [6] MECHANISM OF ANTI-PLATELET AGGREGATING ACTION OF DILAZEP
    TAKENAGA, M
    KITAGAWA, H
    HIRAI, A
    TAMURA, Y
    YOSHIDA, S
    JOURNAL OF PHARMACOBIO-DYNAMICS, 1985, 8 (02): : 77 - 83
  • [7] ANTI-PLATELET AGGREGATORY ACTION OF KOREAN GINSENG
    YAMAMOTO, K
    TERANO, T
    HIRAI, A
    TAMURA, Y
    YOSHIDA, S
    THROMBOSIS AND HAEMOSTASIS, 1989, 62 (01) : 412 - 412
  • [8] IS PROSTACYCLIN A PHYSIOLOGICALLY IMPORTANT CIRCULATING ANTI-PLATELET AGENT
    STEER, ML
    MACINTYRE, DE
    LEVINE, L
    SALZMAN, EW
    NATURE, 1980, 283 (5743) : 194 - 195
  • [9] Platelet-rich plasma and macular hole surgery: A clue to their mode of action and the influence of anti-platelet agents
    D'Alterio, Francesco Maria
    Ferrara, Mariantonia
    Bagnall, Alan
    Talks, Kate L.
    Hillier, Roxane J.
    EUROPEAN JOURNAL OF OPHTHALMOLOGY, 2023, 33 (04) : NP111 - NP114
  • [10] ANTI-PLATELET AGENTS - MECHANISM OF ACTION AND CLINICAL INDICATIONS
    OELZ, O
    SCHWEIZERISCHE MEDIZINISCHE WOCHENSCHRIFT, 1979, 109 (10) : 348 - 353
12345